 | Up a level |
2020
Voelker, Linus A., Kaufeld, Jessica, Miesbach, Wolfgang, Braehler, Sebastian, Reinhardt, Martin 
ORCID: 0000-0002-7862-0993, Kuehne, Lucas, Muehlfeld, Anja, Schreiber, Adrian, Gaedeke, Jens, Toelle, Markus, Jabs, Wolfram J., Oezcan, Fedai, Markau, Silke, Girndt, Matthias ORCID: 0000-0003-2823-0847, Bauer, Frederic, Westhoff, Timm H., Felten, Helmut, Hausberg, Martin, Brand, Marcus, Gerth, Jens, Bieringer, Markus, Bommer, Martin, Zschiedrich, Stefan, Schneider, Johanna, Elitok, Saban, Gawlik, Alexander, Gaeckler, Anja, Kribben, Andreas, Schwenger, Vedat, Schoenermarck, Ulf, Roeder, Maximilian, Radermacher, Joerg, Bramstedt, Joern, Morgner, Anke, Herbst, Regina, Harth, Ana, Potthoff, Sebastian A., von Auer, Charis, Wendt, Ralph, Christ, Hildegard ORCID: 0000-0003-3235-2994, Brinkkoetter, Paul T. and Menne, Jan
(2020).
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.
Blood Adv., 4 (13).
S. 3085 - 3093.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 2473-9537
Voelker, Linus A., Kaufeld, Jessica, Miesbach, Wolfgang, Braehler, Sebastian, Reinhardt, Martin ORCID: 0000-0002-7862-0993, Kuehne, Lucas, Muehlfeld, Anja, Schreiber, Adrian, Gaedeke, Jens, Toelle, Markus, Jabs, Wolfram J., Ozcan, Fedai, Markau, Silke, Girndt, Matthias ORCID: 0000-0003-2823-0847, Bauer, Frederic, Westhoff, Timm H., Felten, Helmut, Hausberg, Martin, Brand, Marcus, Gerth, Jens, Bieringer, Markus, Bommer, Martin, Zschiedrich, Stefan, Schneider, Johanna, Elitok, Saban, Gawlik, Alexander, Gaeckler, Anja, Kribben, Andreas, Schwenger, Vedat, Schoenermarck, Ulf, Roeder, Maximilian, Radermacher, Joerg, Bramstedt, Joern, Morgner, Anke, Herbst, Regina, Harth, Ana, Potthoff, Sebastian A., von Auer, Charis, Wendt, Ralph, Christ, Hildegard ORCID: 0000-0003-3235-2994, Brinkkoetter, Paul T. and Menne, Jan
(2020).
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.
Blood Adv., 4 (13).
S. 3093 - 3102.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 2473-9537
2014
Wehling, Cyrill, Amon, Oliver, Bommer, Martin, Hoppe, Bernd, Kentouche, Karim, Schalk, Gesa, Weimer, Rolf, Wiesener, Michael, Tonshoff, Burkhard and Kirschfink, Michael (2014). Complement activation biomarkers under Eculizumab treatment in patients with atypical hemolytic-uremic syndrome (aHUS), membrano-proliferative glomerulonephritis (MPGN) and antibody-mediated renal graft rejection (AMR). Mol. Immunol., 61 (2). S. 259 - 260. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890